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Abstract
Background: Mental disorders are associated with a
considerable burden of disease as well as being risk
factors for other health outcomes. The new Global
Burden of Disease (GBD) Study will make estimates for
both the disability and mortality directly associated
with mental disorders, as well as the burden
attributable to other health outcomes. Herein we
discuss the process by which health outcomes in
which mental disorders are risk factors are selected
for inclusion in the GBD Study. We make suggestions
for future research to strengthen the body of
evidence for mental disorders as risk factors.
Methods: We identified a list of potential associations
between mental disorders and subsequent health
outcomes based on a review of the literature and
consultation with mental health experts. A two-stage
filter was applied to identify mental disorders and
health outcomes that meet the criteria for inclusion in
the GBD Study. Major limitations in the current
literature are discussed and illustrated with examples
identified during our review.
Results and discussion: Only two associations are
included in the new GBD Study. These associations
are the increased risk of ischemic heart disease with
major depression and mental disorders as a risk factor
for suicide. There is evidence that mental disorders
are independent risk factors for cardiovascular disease
(CVD), type 2 diabetes and injuries. However, these
associations were unable to be included because of
insufficient data. The most common reasons for
exclusion were inconsistent identification of ‘cases’,
uncertain validity of health outcomes, lack of
generalizability, insufficient control for confounding
factors and lack of evidence for temporality.
Conclusions: CVD, type 2 diabetes and injury are
important public health policy areas. Prospective
community studies of outcomes in patients with
mental disorders are required, and their design must
address a range of confounding factors.
Background
New Global Burden of Disease (GBD) Study estimates
due for release in 2012 aim to reflect the impact of mor-
bidity and mortality for all diseases, injuries and risk fac-
tors, including mental disorders [1]. Although disorder-
specific morbidity and mortality are needed for GBD
estimates and to guide health policy in the provision of
treatment services, quantifying the additional burden
due to health outcomes for which those disorders are
risk factors provides an additional evidence base for
developing preventative health policy [2]. The Compara-
tive Risk Assessment (CRA) component within the GBD
Study will be used to evaluate the impact of risk factors
on public health within a unified framework [2].
Risk factors are defined within the CRA as exposures
that increase the probability of disease or injury [3].
Considered in the CRA are risk factors likely to be
among the leading causes of disease burden at a global
or regional level [2]. Other inclusion criteria require that
risk factors be sufficiently well-defined, such that popu-
lation distribution can be quantified and should com-
prise those for whom the exposure is modifiable [2].
CRA requirements specify that data should be available
to quantify the risk of health outcomes for given expo-
sures and sufficient strength of evidence for causality
based on collective scientific knowledge [2].
In considering strength of evidence for risk factors in
health outcomes, the Bradford-Hill criteria are widely
accepted as a guide for assessing the evidence base [4,5].
The Bradford-Hill criteria describe the best evidence as
that which demonstrates the strength and consistency of
the relationship, the specificity of the risk factor and
outcome, a temporal sequence in which the risk
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as the effect of preventative action [4].
Although previous GBD studies included outcomes for
illicit drug use and alcohol use [6], the current GBD
Study is the first in which other mental disorders are
considered as independent risk factors for other health
outcomes. A growing body of literature reports links
between mental disorders and other health conditions.
Higher rates of morbidity and mortality have been
reported in psychiatric patients for decades. Longitudi-
nal studies have demonstrated links between mental dis-
orders and cardiovascular disease [7], metabolic disease
[8] and injury [9].
Our aim in this paper was not to present the results of
a series of systematic reviews of the strength of evidence
for health outcomes. To review the evidence compre-
hensively, each potential outcome for mental disorders
deserves in-depth discussion beyond the scope of this
paper. Rather, this paper describes the process by which
health outcomes were selected for inclusion in the GBD
2010 Study. We identify the most common reasons that
potential outcomes were not included and provide sug-
gestions for future research. The GBD CRA component
for illicit drug use and alcohol use is outside the scope
of this paper and will be reported separately by the
groups undertaking that work.
Methods
We reviewed the current literature for data on the
strength of evidence for mental disorders as risk factors
for other health outcomes. Mental disorders included in
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disorders (major depression and dysthymia), bipolar dis-
order, schizophrenia, eating disorders, autistic spectrum
disorders, conduct disorder and attention-deficit/hyper-
activity disorder (ADHD). Patients with these disorders
are defined as those meeting the diagnostic criteria for
either the ICD-10 Classification of Mental and Beha-
vioural Disorders: Diagnostic Criteria for Research (ICD-
10) classification system [10] or the Diagnostic and Sta-
tistical Manual of Mental Disorders, Fourth Edition-
Text Revision (DSM-IV-TR) [11]. The disorders should
not be substance-induced or due to a general medical
condition, as these are covered under other categories
within the GBD 2010 Study.
Potential health outcomes were identified using a con-
sultative heuristic approach. Good-quality, peer-reviewed
evaluations of the literature were initially sought. A
review by Prince and colleagues [12] provided the basis
for subsequent investigation. Outcome-specific reviews
were then identified to examine the breadth of data
available to determine the strength of the evidence. We
consulted mental health epidemiologists and clinicians
with a special interest in the field, and their suggestions
were included. The Mental Disorders and Illicit Drug
Use Expert Group was then invited to provide feedback
on the proposed outcomes and to contribute additional
suggestions.
A two-stage filter was then applied to identify those
associations that met criteria for inclusion based on the
parameters of the GBD 2010 Study and the specific
requirements for risk factors and outcomes of the CRA
project. The outcomes were first filtered by the GBD
Study requirement that the resulting health condition
must fall within the study classifications of disease and
injury. The second filter focused on the CRA require-
ments. These criteria included clear definition of risks
and outcomes and sufficient strength of evidence for an
independent association guided by the Bradford-Hill cri-
teria. GBD Study estimates aim to reflect loss of health.
The methodology excludes ‘out of skin’ elements of
functioning, such as participation restrictions which,
though important, are beyond the scope of what is cap-
tured by disability-adjusted life years [13,14]. Therefore,
outcomes such as social consequences are beyond the
scope of this study.
Results
A number of good-quality reviews of health outcomes
for patients with mental disorders were identified
[7-9,12,15]. These reviews informed the initial list of
health outcomes. Six health outcomes were considered
after application of the first filter (Table 1). Examples of
associations that did not meet GBD Study criteria were
those with non-health-related outcomes, such as
increased risk of unemployment arising from depression
[16].
After applying the second filter, sufficient evidence
was identified to include attributable burden for two
health outcomes: suicide and ischemic heart disease
[17]. A report of data identified for major depression,
schizophrenia, bipolar disorder, anxiety disorders and
anorexia nervosa as risk factors for suicide is currently
in preparation and will be submitted for peer review
Table 1 Health outcomes for mental disorders considered
for inclusion in the Comparative Risk Assessment
component within the Global Burden of Disease study*
Mental disorder as risk factors Health outcomes
Depression, bipolar disorder and anxiety disorders CHD
Depression and anxiety disorders CVD
Depression, bipolar disorder and schizophrenia Type 2 diabetes
Pervasive developmental disorders Injury
Childhood behavioural disorders Injury
Mental disorders Suicide
CHD = coronary heart disease; CVD = cardiovascular disease. *Following
application of the first filter: Global Burden of Disease 2010 requirements for
inclusion.
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ditions were included in the CRA component of the
GBD 2010 Study, a reasonable question is why the attri-
butable burden of other health outcomes is not reflected
in the estimates. To illustrate the nature of the limita-
tions in the current literature, examples are provided for
associations that are likely to have a substantial impact
on the global burden of disease.
Discussion
The most significant factors that limited inclusion of
studies and ultimately prevented inclusion of other
health outcomes in the new GBD Study estimates are
(1) risk factor case identification, (2) health outcome
case identification, (3) generalizability, (4) confounding
factors and (5) temporality.
Risk factor case identification
To attribute the proportionate burden of a condition,
both risks and outcomes must be clearly defined [18].
For inclusion in the GBD CRA component, mental dis-
orders considered as risk factors must meet the DSM-
IV-TR or ICD-10 diagnostic criteria, which require a
threshold level of symptomatology and, in some cases,
impairment. The current strength of evidence for disor-
ders such as anxiety disorders and childhood beha-
vioural disorders as risk factors is hampered by the lack
of consistency in the definitions used to determine the
presence of these disorders.
Inconsistent definitions
In our review, we found that the definitions used when
mental disorders were considered as risk factors varied
considerably. The most common issue identified was the
use of broad definitions, such as the use of ‘anxiety’ but
its’ being unclear with regard to whether this term
referred to an anxiety disorder that met diagnostic cri-
teria. Some studies tend to describe anxiety as being
present on the basis of dimensional scales. These scales
(for example, brief symptom checklists, lists of personal-
ity traits or measures of psychological distress) can be
administered quickly and demonstrate good sensitivity.
However, their low specificity [19] results in the inclu-
sion of cases of anxiety that do not reach the threshold
for a diagnosis. The issue is highlighted by a meta-analy-
tic review of 21 studies exploring anxiety constructs and
incident CHD and cardiac mortality [7]. Only two stu-
dies that reported a significant association defined ‘anxi-
ety’ according to DSM-IV-TR and/or ICD-10 diagnostic
criteria [7]. Whilst acknowledging that symptoms of
mental disorders occur along a continuum, a threshold
must be employed to derive comparable estimates of
attributable burden. The question whether psychological
distress and anxiety symptoms increase the risk for
CHD is valid, but it does not directly allow for estima-
tion of the extent to which one disorder (in this case, an
anxiety disorder) is a risk factor for another disorder
(CHD).
Incomplete identification of cases
Cross-sectional studies rely on retrospective data collec-
tion to establish patients’ mental health history. These
studies need to be interpreted with caution, as the accu-
racy of recall of symptoms of mental disorders is unreli-
able [20]. To illustrate, clinically defined ADHD requires
the onset of symptoms and impairment before age seven
years [11]. Based on recall, the onset for externalizing
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oppositional defiant disorder (ODD) is generally esti-
mated to be later than actual onset [21], resulting in
potential misclassification of cases as noncases. Higher
rates of accidental injury are reported for people with
behavioural disorders such as ADHD [22,23]; however,
recall bias increases the chance that cases of ADHD are
treated as noncases. In trying to quantify the increased
risk due to mental disorders, variably defined ‘cases’
limit the ability to infer a consistent relationship because
the characteristics of people with the risk factor are
likely to be inconsistent between studies.
Health outcome case identification
The CRA framework requires that attributable burden
be associated with a specific health condition [2]. A
number of proposed outcomes could not be included
because of the reliability of studies on self-reported
measures (for example, type 2 diabetes) or on outcomes
not specific to a health condition, such as vehicular
accidents.
Health outcomes that cannot be verified
Biomedical measures are rarely collected in community-
based studies, relying instead on self-report of health
outcomes. The accuracy of self-report measures depends
on the community rate of diagnosis and participants’
recall and knowledge. Chronic diseases such as type 2
diabetes are particularly difficult to identify on the basis
of survey data. In developed countries, almost 50% of
type 2 diabetes cases are undiagnosed [24]. In a sample
of patients with clinically diagnosed diabetes, only two
of three patients self-reported the presence of diabetes
[25]. Systematic underreporting of the outcome may
underestimate or obscure the association between risk
and outcome.
Outcomes that cannot be mapped to a health condition
An additional issue related to outcomes is the reporting
of events (for example, vehicle collisions) rather than
the health implication of the event (for example,
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strong evidence for an association between ADHD and
negative driving injury outcomes, including poor perfor-
mance on simulators, traffic violations and motor vehi-
cle collisions [9,26]. A causal pathway is plausible,
considering that common ADHD characteristics include
inattention, distractibility, impulsiveness and slow pro-
cessing ability [9]. However, the usability of findings is
limited in the attribution of disease burden because of
the lack of information regarding specific health
outcomes.
Generalizability of the sample
Prospective longitudinal studies of outcomes in repre-
sentative community cases of mental disorders are
lacking, especially for severe mental disorders such as
bipolar disorders and schizophrenia. As estimates of
attributable burden in the GBD CRA component are
applied at the population level, studies with samples
not sufficiently representative of the general population
could not be included. For example, a number of well-
conducted studies examining bipolar disorder [27-29]
and schizophrenic disorders [27] as risk factors for
chronic disease focused on clinical samples. Hospita-
lized patients have more complex psychopathology and
psychological-physical comorbidity that lead to greater
risk of negative health outcomes. The degree of asso-
ciation may be overestimated if only severe cases are
included.
Clinical samples are subject to a number of biases
which may not be controlled for. Clinically ascertained
samples are likely to have received treatment, with treat-
ment rates generally being lower in community samples.
Because of their use of health services, psychiatric
patients with independent risk factors for physical disor-
ders (for example, hypertension) are more likely to have
these risk factors recognized and treated compared to
community cases. Such sources of systemic bias hamper
interpretation of studies based on clinical samples. This
limits the generalizability of the risk for health outcomes
at the population level.
Confounding factors
An important issue in establishing the strength of evi-
dence is whether the association persists after adjust-
ment for confounding factors. A confounder is a
variable that can cause or prevent the outcome and is
also associated with the risk factor [30]. This may lead
to a false-positive that erroneously suggests a causal
relationship between the dependent variable and the
outcome. Type 2 diabetes and CHD are examples of
outcomes for which we found the strength of the
evidence was further limited because of inability to con-
trol for multiple risk factors.
Causal pathways of chronic disease and injury are gen-
erally multifactorial. For example, the INTERHEART
Study identified nine potentially modifiable risk factors
for acute myocardial infarction, including lipid abnorm-
ality, hypertension, diabetes, abdominal obesity, con-
sumption of fruits and vegetables, smoking, alcohol
intake, physical activity and psychosocial factors [31].
Mental disorders are independently associated with
many of these risk factors [32]. To clarify the relation-
ship between mental disorders and CHD, analyses need
to control for potentially confounding effects, given the
network of factors involved in the development of CHD.
Adjustment for comorbidity
A review of the literature [7] found that the majority of
studies that examined anxiety disorders and CHD con-
trolled for smoking and physiological factors, yet only
two studies reported adjustment for depressive symp-
toms and none adjusted for the impact of other comor-
bid mental disorders. Anxiety disorders frequently co-
occur with other mental disorders, such as mood disor-
ders and substance abuse [33], which may have a syner-
gistic effect on the development of chronic health
conditions [34].
The confounding factors that can be considered in a
study vary considerably, due in part to limitations such
as cost and burden on respondents. Moreover, insuffi-
cient numbers of patients meeting the criteria for the
confounder, such as comorbid mental disorders, reduce
researchers’ capacity to detect an effect. For example, a
long-term prospective study of the risk of CHD in com-
munity cases of anxiety disorder found that a significant
association remained after controlling for a range of
confounders [32], but the investigators were unable to
control for comorbid depression. The reason for this
was that the low number patients with comorbid
depression and anxiety prevented adjustment for poten-
tially additive effects of this comorbidity (personal corre-
spondence{ I. Janszky, 2011 }).
Effects of treatment
Treatment of a mental disorder affects the course of the
disorder and also introduces the risk of iatrogenic out-
comes, such as glucose intolerance or atherosclerosis.
Reliable data on treatment regimen, including medica-
tions, are rarely captured or controlled for in commu-
nity studies. Researchers in prospective studies of
depression and CVD, for example, either do not collect
treatment data [35] or collect incomplete information
[36].
Treatment may increase the risk of negative health
outcomes in some cases or may provide a protective
Baxter et al. BMC Medicine 2011, 9:134
http://www.biomedcentral.com/1741-7015/9/134
Page 4 of 7effect in others. Antipsychotic medications have a well-
known potential to increase the risk of obesity and
abnormal glucose metabolism [15]. Observational stu-
dies of women have found that antidepressant use is
associated with an increased risk of sudden cardiac
death [37] and stroke [38]. Conversely, it has been pos-
tulated that the reduction in the duration of psycho-
pathology and symptom severity due to treatment may
reduce the risk for chronic physical disease. A potential
mechanism suggested by animal studies is that antide-
pressants may inhibit the expression of proinflammatory
cytokines implicated in the progression of CVD [39]. To
clarify the multidirectional impact of treatment on
health outcomes, researchers need to consider the inter-
actions between treatment type, symptom severity and
potential comorbidities.
Environmental factors
T h ec u r r e n tl i t e r a t u r es u g gests a strong link between
childhood psychopathology, such as autistic disorders
and behavioural disorders, and increased risks for acci-
dental and self-inflicted injuries [40-42]. However, inclu-
sion for CRA is hindered by unrepresentative sampling
(registry data or small sample sizes) and lack of data on
potential comorbid and environmental risk factors.
Common comorbid conditions, including epilepsy and
intellectual disability [43], and environmental factors,
such as the family context and unsafe physical environ-
ments [42], may inflate the risk of injury. Obtaining
objective data on family and physical environments is
difficult and is rarely collected when children with inju-
ries present for treatment.
Temporality
Determining temporality and establishing which condi-
tion precedes the other constitute the greatest areas of
contention in establishing an argument for mental disor-
ders as a risk factor. Temporality of onset is subject to
bias arising from self-report of onset and from the use
of routinely collected clinical data. Prospective cohort
studies, whilst still subject to some degree of bias, pro-
duce the best empirical evidence for temporality in risk
factor associations.
Clinical data
Bias can arise from medical records, which document
the diagnosis and the start of treatment more accurately
than the onset of the disorder. Symptoms of mental dis-
orders and chronic physical health conditions are often
present for some time prior to clinical diagnosis. For
example, studies based on data linkage of medical
records have reported higher rates of type 2 diabetes in
people diagnosed with a mental disorder [27,44]. When
the diagnosis of either a mental disorder or diabetes
precedes the other, the one diagnosed first may be a
risk factor for the other. However, temporal pathways
are complicated by the lag time between the onset of
the disorder and diagnosis. The high rate of undiag-
nosed diabetes [24] and the delay between symptom
onset and diagnosis of mental disorders confounds
temporality.
Recall bias
Because of recall bias, inaccurate estimates of the occur-
rence of disorders can arise from retrospectively col-
lected survey data. For instance, brain injury can induce
neurobehavioral changes. However, the subsequent
effects can be delayed, as the more significant damage
tends to ensue from a series of interrelated processes
that affect the central nervous system [45]. If the injury
leads to cognitive or behavioural changes, incorrect
recall of the onset of occurrence might lead to the
assumption that childhood disorders are a risk factor
rather than an outcome.
Future directions for research
Recommendations for future research required to
address gaps in the current body of evidence can be
generically applied across the majority of risk factors
and related health outcomes. Prospective studies of
representative community samples using clear and
consistent definitions of the mental disorder and out-
come are essential to providing evidence for risk. Con-
founding factors need to be considered, including
identifying and controlling for comorbid physical and
mental disorders. Specific recommendations are sum-
marized in Table 2.
Summary
Whilst preliminary evidence suggests that mental disor-
ders are linked to a range of poor health outcomes,
further research is needed to confirm the strength of
these relationships. The criteria discussed in this paper
may be useful in the design of future studies. CVD, dia-
betes and accidental injury are major areas of concern
for public health policy. If mental disorders are indeed
shown to be independent risk factors for these out-
comes, accurate diagnosis and treatment of mental dis-
orders may lead to a reduction in the global burden of
important health outcomes. As more consistent and
compelling evidence becomes available, it is anticipated
that these health outcomes will be considered for inclu-
sion in future burden-of-disease studies.
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